Accriva Diagnostics, Inc. recalls directCHECK ACT-LR whole blood quality control
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Assayed Whole blood control contains labeling with incorrect performance range.
- Products
-
- directCHECK ACT-LR whole blood quality control
- Company
- Accriva Diagnostics, Inc.
- Where it was sold
-
Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, FL, GA, ID, IL, IN, KY, MA, MD, MI, MN, MO, MT, NC, NJ, NM, NY, OH, OK, PA, SC, TN, TX, VA, VT, WA, WI, WV and the countries of Canada, Hong Kong, Spain.
Nationwide
- Units affected
- 6060
- About this recall
- directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2